BALYASNY ASSET MANAGEMENT L.P. - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q1 2023$4,611,760
-29.7%
1,450,239
+53.0%
0.01%
-33.3%
Q4 2022$6,557,440
+775.5%
947,607
+700.8%
0.02%
+800.0%
Q3 2022$749,000
+98.7%
118,333
+30.0%
0.00%
+100.0%
Q2 2022$377,000
-69.9%
91,028
+215.0%
0.00%
-85.7%
Q4 2020$1,251,000
-93.2%
28,900
-91.6%
0.01%
-94.8%
Q3 2020$18,452,000
+710.4%
342,014
+1810.4%
0.14%
+800.0%
Q2 2019$2,277,000
-77.6%
17,903
-72.3%
0.02%
-77.9%
Q1 2019$10,185,000
+15.0%
64,738
-27.5%
0.07%
+6.2%
Q4 2018$8,857,000
-74.3%
89,281
-62.1%
0.06%
-59.0%
Q3 2018$34,425,000
-44.8%
235,787
-40.6%
0.16%
-44.9%
Q2 2018$62,339,000
+12.8%
397,190
+22.8%
0.28%
+23.0%
Q1 2018$55,244,000
+54.7%
323,539
+61.3%
0.23%
+105.4%
Q4 2017$35,715,000
-60.2%
200,533
-69.3%
0.11%
-68.2%
Q3 2017$89,707,000
+119.4%
653,122
+67.8%
0.35%
+108.3%
Q2 2017$40,883,000
-23.8%
389,181
-34.1%
0.17%
-32.4%
Q1 2017$53,665,000
+23.2%
590,378
-16.4%
0.25%
+6.8%
Q4 2016$43,562,000
+17.1%
706,035
+28.7%
0.23%
+8.8%
Q3 2016$37,190,000
+281.6%
548,684
+143.7%
0.22%
+241.3%
Q2 2016$9,747,000
+6.3%
225,167
+4.4%
0.06%
+16.7%
Q1 2016$9,166,000
+6.3%
215,660
+60.6%
0.05%
-10.0%
Q4 2015$8,622,000
+2055.5%
134,261
+2768.8%
0.06%
+1900.0%
Q3 2015$400,0004,6800.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,335,528$40,104,0004.92%
qPULA Trading Management LP 14,344$91,0000.80%
Frazier Life Sciences Management, L.P. 1,440,757$9,120,0000.70%
Ikarian Capital, LLC 462,628$2,928,0000.58%
Birchview Capital, LP 98,000$620,0000.44%
HealthCor Management, L.P. 455,000$2,880,0000.36%
Financial Advocates Investment Management 45,071$3,538,0000.29%
PDT Partners, LLC 262,767$1,663,0000.25%
Monaco Asset Management SAM 80,000$506,0000.19%
Summit X, LLC 103,424$651,0000.19%
View complete list of BLUEBIRD BIO INC shareholders